Spok (SPOK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Feb, 2026Executive summary
Achieved strong Q4 and full-year 2025 results, with net income up 6.1% and software bookings rising 14% year-over-year and 83% sequentially in Q4.
Maintained leadership in healthcare communications, serving over 2,200 hospitals and operating the largest U.S. paging network with 675,000 units in service.
Strategic focus on growing software revenue, generating cash, and returning capital to stockholders, with $27.3 million returned in 2025 and nearly $730 million since 2004.
Maintains a debt-free balance sheet and strong cash position, with $25.3 million in cash and equivalents at year-end 2025.
Recognized for top-rated secure messaging and clinical communication solutions for the ninth consecutive year.
Financial highlights
2025 GAAP net income was $15.9 million ($0.75 per diluted share), up from $15 million ($0.73) in 2024; basic EPS was $0.77, up from $0.74.
Total GAAP revenue reached $139.7 million, up from $137.7 million in 2024; recurring revenue accounted for over 80% of total revenue.
Software revenue grew 4.8% to $67.2 million, driven by a 24% increase in professional services revenue; wireless revenue declined 1.4% to $72.5 million.
Adjusted EBITDA for 2025 was $29 million, maintaining a 21% margin and nearly flat year-over-year.
$27.3 million was returned to stockholders in 2025 via dividends and share repurchases.
Outlook and guidance
2026 revenue guidance: $136–$143 million, with a higher mix of software revenue and wireless revenue expected between $68–$71 million.
Software revenue expected at $68–$72 million; adjusted EBITDA guidance: $27.5–$32.5 million.
Growth driven by higher-margin software bookings; expect to pay dividends exceeding $27 million in 2026.
Latest events from Spok
- Recurring revenue, strong cash flow, and top hospital relationships fuel growth and returns.SPOK
Investor presentation - Software bookings up 92%, record EBITDA, and strong capital returns in Q2 2026.SPOK
Q2 2026 - All proposals, including board elections and compensation, were approved by shareholders.SPOK
AGM 2026 - Key votes include director elections, auditor ratification, and executive compensation approval.SPOK
Proxy filing - Board recommends all proxy proposals, highlighting strong governance and ESG focus.SPOK
Proxy filing - Recurring revenue and top hospital relationships fuel growth, cash flow, and shareholder returns.SPOK
Investor presentation - Q1 2026 saw revenue fall 8.5%, but software managed services surged 57% and $8M was returned.SPOK
Q1 2026 - Software bookings surged over 64% year-over-year, driving backlog and ARPU growth.SPOK
Q3 2024 - Q2 revenue and net income declined, but software bookings rose and capital returns remained strong.SPOK
Q2 2024